Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.150
+0.003 (2.04%)
At close: Mar 10, 2026

Shenzhen Neptunus Interlong Bio-technique Company Company Description

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.

The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders.

It also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business.

Shenzhen Neptunus Interlong Bio-technique Company Limited was incorporated in 2002 and is based in Quarry Bay, Hong Kong.

Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

Shenzhen Neptunus Interlong Bio-technique Company Limited
Country China
Founded 2002
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,474

Contact Details

Address:
One Taikoo Place
Quarry Bay
Hong Kong
Website interlong.com

Stock Details

Ticker Symbol 8329
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100000775
SIC Code 2836

Key Executives

Name Position
Feng Zhang Executive Chairman and Compliance Officer
Jian Bo Huang Vice GM, Financial Controller, Joint Company Secretary, Board Secretary and Executive Director
Xiao Guang Zhang Executive Director
Yang Cao Human Resources Director and Employee Representative Supervisor
Wai Sum Fung A.C.I.S., A.C.S. Joint Company Secretary